1986PD - HORAS5 promotes cabazitaxel resistance in castration resistant prostate cancer via a BCL2A1-dependent survival mechanism
| Autor: | Pucci, P. 1, Venalainen, E. 2, Alborelli, I. 3, Quagliata, L. 4, Mather, R. 1, Rigas, S. 1, Romero, I. 1, Wang, Y. 5, Crea, F. 1 |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v798-v798 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|